What is the best management approach for a patient with advanced ovarian cancer, intestinal pseudo-obstruction, and impaired renal function to improve quality of life and alleviate symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The best management approach for a patient with advanced ovarian cancer, intestinal pseudo-obstruction, and impaired renal function should focus on symptom control and quality of life improvement through a multimodal strategy. Initial management should include careful medication adjustment with renal dose modifications, particularly avoiding NSAIDs and nephrotoxic agents. For intestinal pseudo-obstruction, a combination of prokinetics like low-dose metoclopramide (5mg TID, adjusted for renal function) or domperidone (10mg TID) can be used, along with bowel decompression via nasogastric tube if needed. Antiemetics such as ondansetron (4mg BID) or haloperidol (0.5-1mg BID) can help control nausea. Pain management should utilize opioids with less renal impact like fentanyl (12-25mcg/hr patch) or hydromorphone with appropriate dose reductions. Nutritional support through parenteral nutrition may be necessary if enteral feeding is not tolerated. Palliative procedures like paracentesis for ascites or consideration of a venting gastrostomy tube can provide significant symptom relief. Ongoing oncology consultation should evaluate if low-toxicity chemotherapy options remain viable. This approach addresses the complex interplay between cancer symptoms, pseudo-obstruction, and renal dysfunction while prioritizing comfort and function, recognizing that medication clearance is compromised by renal impairment, necessitating careful dosing to prevent toxicity, as supported by the American Society of Clinical Oncology statement on individualized care for patients with advanced cancer 1.

Some key considerations in managing this patient include:

  • Careful assessment of the patient's needs, goals, and preferences throughout the course of illness, as emphasized by the American Society of Clinical Oncology 1
  • The use of parenteral nutrition in patients with advanced cancer and intestinal failure, as recommended by the ESPEN guidelines on nutrition in cancer patients 1
  • The importance of symptom management, including the use of prokinetics, antiemetics, and opioids, as discussed in the evidence-based recommendations for cancer nausea and vomiting 1
  • The potential benefits and limitations of disease-directed therapy, and the role of palliative care in improving quality of life, as highlighted by the American Society of Clinical Oncology statement on individualized care for patients with advanced cancer 1.

Overall, the management of this patient requires a comprehensive and individualized approach that prioritizes symptom control, quality of life, and patient-centered care, as supported by the evidence from 1, 1, 1, 1, and 1.

From the Research

Patient Management Approach

To improve the quality of life and alleviate symptoms for a patient with advanced ovarian cancer, intestinal pseudo-obstruction, and impaired renal function, a comprehensive management approach is necessary. The following points should be considered:

  • A multidisciplinary team approach, including healthcare professionals from various specialties, is essential for providing high-quality patient care 2.
  • Effective communication and collaboration among team members are crucial for addressing the patient's complex needs 2.
  • A comprehensive patient history should be taken to inform diagnosis and treatment, using a structured but flexible process of gathering relevant information from patients 3.
  • The patient's symptoms, such as intestinal pseudo-obstruction, vomiting, and weakness, should be managed using a multimodal approach, including medical, nutritional, and supportive care.
  • The patient's decision to forgo palliative chemotherapy due to concerns about quality of life and potential side effects should be respected and supported.
  • Alternative management strategies, such as radiotherapy, should be considered to alleviate symptoms and improve quality of life.
  • The patient's nutritional status, including iron and protein levels, should be monitored and managed accordingly, as iron deficiency anemia can exacerbate symptoms 4.
  • A multidisciplinary consultation service can provide support and guidance for primary care providers managing complex patients with pain and addiction 5.
  • The patient's overall well-being, including physical, psychological, and emotional health, should be prioritized and addressed through a comprehensive and evidence-based approach 6.

Symptom Management

The patient's symptoms, including:

  • Intestinal pseudo-obstruction
  • Vomiting
  • Weakness
  • Dizziness
  • Swollen feet
  • Diarrhea should be managed using a multimodal approach, including:
  • Medical management, such as medications to alleviate symptoms
  • Nutritional support, such as protein shakes and liquid iron
  • Supportive care, such as physical therapy and emotional support
  • Alternative therapies, such as radiotherapy, to alleviate symptoms and improve quality of life.

Multidisciplinary Team Approach

A multidisciplinary team approach, including healthcare professionals from various specialties, such as:

  • Oncology
  • Gastroenterology
  • Nephrology
  • Palliative care
  • Nutrition
  • Physical therapy should be used to provide comprehensive care and address the patient's complex needs 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effective multidisciplinary working: the key to high-quality care.

British journal of nursing (Mark Allen Publishing), 2014

Research

How to take a comprehensive patient history.

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association, 2024

Related Questions

What is the differential diagnosis for a female with abdominal cramping, frequent urination, and delayed menstruation, with negative urine pregnancy and dipstick results, and a history of sexual activity?
What is the appropriate workup and differential diagnosis for a 21-year-old female with chronic facial, neck, and scalp pain, who has a normal (Magnetic Resonance Imaging) MRI, overbite, and temporomandibular joint (TMJ) symptoms, including jaw popping and point tenderness?
What is the recommended next step in evaluating a 24-year-old female with chronic generalized abdominal pain, gas, bloating, and intermittent diarrhea, who has a history of ovarian cysts and appendectomy, with normal laboratory results, including a normal white blood cell (WBC) count, and has been avoiding gluten?
What are the preoperative concerns for a 35-year-old white male with a past medical history (PMH) of alcoholism, Gastroesophageal Reflux Disease (GERD), Obstructive Sleep Apnea (OSA), and bipolar disorder, who is on Bilevel Positive Airway Pressure (BiPAP) therapy, taking Nexium (esomeprazole), Disulfiram (generic), and Propranolol (as needed), with a history of medical recommendations for bariatric surgery?
Is a headache in a 15-year-old patient with Obsessive-Compulsive Disorder (OCD) likely due to sertraline (Zoloft), given that the headache worsened after the dose was increased to 75 milligrams?
What is the initial treatment for heart failure, particularly for patients with reduced ejection fraction?
What is the maximum dosage of heart failure medications such as Angiotensin-Converting Enzyme (ACE) inhibitors, beta-blockers, and Mineralocorticoid Receptor Antagonists (MRAs) like lisinopril, carvedilol, and spironolactone?
What is the best approach to manage a 62-year-old patient with recurrent ovarian cancer, intestinal pseudo-obstruction, and impaired quality of life?
How long after starting metformin (biguanide) 1000 mg twice a day (bid) would a male patient with chronic candidal balanitis and hyperglycemia (A1c of 8.6%) start seeing improvement in his genitourinary symptoms?
What is the approach to diagnosing androgen insensitivity syndrome (AIS)?
Is skipping breakfast a risk factor for developing gallstones?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.